1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Histologic types and frequencies of parotid lesions
Histologic Types Surgical Findings Superficial Lobe Deep Lobe Benign tumors Pleomorphic adenoma 57 44 13 Warthin tumor 15 13 2 Basal cell adenoma 3 2 1 Myoepithelioma 1 1 0 Lymphoepithelial cyst 3 3 0 Reactive lymphadenopathy 1 1 0 Inflammation 1 1 0 Malignant tumors Malignant lymphoma 1 1 0 Metastatic tumor 2 2 0 Oncocytic carcinoma 1 1 0 Acinic cell carcinoma 2 2 0 Carcinoma ex pleomorphic adenoma 1 1 0 Basal cell adenocarcinoma 1 1 0 Salivary duct carcinoma 2 2 0 Total 91 75 16